ALFA Finder
The call ran from 12:31 PM to 1:28 PM IST (58 min).
Key takeaways
Tarsons delivered record quarterly revenue but gross margins are under severe pressure from surging crude-linked raw material costs.
| Management target | Revenue FY28 |
|---|
| Revenue growth | Consolidated revenue grew 21% YoY to ₹115 Cr. |
|---|---|
| Margins | Gross margins contracted 500 bps due to crude price spikes. |
| Demand visibility | Strong uptake in pharma and healthcare; export inquiries rising. |
| Management confidence | Optimistic on volume recovery despite external raw material headwinds. |
Growth
Revenue grew 21% YoY, primarily volume-led by the domestic pharma and export segments.
Outlook
Revenue potential of ₹800 Cr expected across old and new facilities by FY28.
Risks
Raw material costs surged 30-50%, leading to a 500 bps gross margin contraction.
Last quarter's promises, checked
Delivered
- Guided FY27 growth ≥15% → Q2 revenue +21% YoY (= BEAT)
Partly delivered
- Guided ₹40-50 Cr debt cut YoY → gross debt ₹380 Cr (Q1) to ₹370-380 Cr (Q2) (= PARTIAL)
- Guided Panchla+Amta 20-25% of FY28 standalone revenue → FY28 not reached, unverifiable (= PARTIAL)
Missed
- Guided full commissioning in Q2 FY27 → final phase ongoing; only cell culture and radiation lines live (= MISS)
- Guided price hikes fully flow through with one-quarter lag → inflation not fully offset (= MISS)
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Tarsons Products Q2 FY27 Results: Net Loss of ₹0.3 Cr
Tarsons Products Ltd reported revenue from operations of ₹123.7 Cr (+20.9% YoY) and a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
What management said last time
Full summary →From the call summary published .
Outlook they gave
Management expects 15% sustainable growth; new facilities (Panchla/Amta) targeted to contribute 20-25% of standalone revenue by FY28.
Growth they described
Standalone revenue rose 21% to ₹86Cr; growth is primarily volume-led from existing products with minimal new-facility contribution.
Call details
| Company | Tarsons Products Limited |
|---|---|
| NSE symbol | TARSONS |
| ISIN | INE144Z01023 |
| Call | Q2 FY27 earnings call |
| Date | Friday, 13 November 2026 |
| Time | 12:30 PM IST |
| Length | 58 min |
| Audio | Our stream on YouTube ↗ |
Tarsons Products Limited: key numbers
- Share price
- ₹315.45
- Market cap
- ₹1,678 Cr
- Revenue (annual)
- ₹422.5 Cr
- Net profit (annual)
- ₹14.32 Cr
- P/E (TTM)
- 225.9×Sector 55.1×
- Promoter holding
- 47.30%+0.00% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Fri, 13 Nov
Today's concalls →
